There is limited evidence on effective care models for diabetic retinopathy in Indigenous Australians, so Rosamond Gilden conducted her own...
Read moreWhether ophthalmologists are scanning a three-month-old or elderly patient, the ability of Optos ultra-widefield imaging devices to capture 200°...
Read moreThe US FDA has approved the use of high dose Eylea (aflibercept) for three macular conditions, equating to longer intravitreal...
Read moreMissed health checks – including eye examinations – reduced access to routine healthcare for people living with type 2 diabetes...
Read moreThere are up to 1.9 million people living with diabetes in Australia. Of those, research suggests 800,000 don’t access routine...
Read moreA new Diabetes Australia (DA) report has revealed the spiralling impact of diabetes and warned that unless urgent action is...
Read moreDr James Muecke, Australian of the Year 2020 and passionate advocate for type 2 diabetes prevention, has shared a positive...
Read moreA pioneering study out of Western Australia has shown that a longer acting intravitreal dexamethasone implant (DEX-implant) may lead to...
Read moreAn Australian researcher has contributed to a new study demonstrating that lower carbohydrate consumption can potentially put type 2 diabetes...
Read moreThe Australian Society of Ophthalmologists (ASO) has joined forces with Australian of the Year Dr James Muecke ahead of this...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited